Comparison of Follow-up Protocols in Terms of Fetal, Neonatal and Maternal Results in Intrauterine Growth Retardation
NCT04141189 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 206
Last updated 2020-02-12
Summary
This study will be undertaken to determine whether the frequency of fetal surveillance can be safely reduced from bi-weekly to weekly in the case of fetusus with intrauterine growth restriction.
Conditions
- Fetal Surveillance
- Intrauterine Growth Restriction
Interventions
- PROCEDURE
-
weekly
fetal surveillance frequency
- PROCEDURE
-
bi-weekly
fetal surveillance frequency
Sponsors & Collaborators
-
Bezmialem Vakif University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-11-15
- Primary Completion
- 2020-10-15
- Completion
- 2020-11-15
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Infants With Intrauterine Growth Restriction
NCT02515292 ·Status: UNKNOWN
-
A Phase 2, Safety and Dose-Finding Study in Treatment-Naive, Pre-Pubertal, Growth Hormone-Deficient Children
NCT02092077 ·Status: TERMINATED ·Phase: PHASE2
-
Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years
NCT00184691 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency
NCT00490191 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Somatropin Produced by Laboratory Blausiegel Indústria e Comércio Ltda., Compared to Saizen® From Laboratory Merck Serono S.A.
NCT01494779 ·Status: UNKNOWN ·Phase: PHASE1
-
Retrospective Study Of The Influence Of Age At Start Of Growth Hormone Treatment On Height Gain In Children Born Small for Gestational Age
NCT01897753 ·Status: COMPLETED
-
Growth Hormone Treatment in Children Born Small for Gestational Age (SGA)
NCT00184717 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a High Dosage Compared to the Label Dosage of Somatropin in Early Pubertal Stage Children With Growth Hormone Deficiency
NCT00191165 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
NCT02243852 ·Status: WITHDRAWN
-
Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age
NCT00557336 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age
NCT01491854 ·Status: TERMINATED ·Phase: NA
-
Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
NCT00488124 ·Status: COMPLETED ·Phase: PHASE2
-
Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
NCT01237041 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
NCT06768411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
NCT07260500 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients
NCT02042170 ·Status: COMPLETED ·Phase: PHASE2
-
Low and Conventional Dose of Somatropin in Growth Hormone Deficient Adult Patients
NCT00570011 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
NCT02616562 ·Status: COMPLETED ·Phase: PHASE2
-
Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency
NCT03249480 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Long-term Somatropin Treatment in Children
NCT01543867 ·Status: COMPLETED
-
Treatment of Children With Insufficient Secretion of Growth Hormone
NCT00271518 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
NCT00120497 ·Status: UNKNOWN
-
Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children
NCT01613573 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
NCT05894876 ·Status: TERMINATED